US HB7253 | 2021-2022 | 117th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 3-1)
Status: Introduced on March 28 2022 - 25% progression, died in committee
Action: 2022-03-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 28 2022 - 25% progression, died in committee
Action: 2022-03-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to provide for clarification of requirements for the remanufacturing of medical devices, and for other purposes.
Title
Clarifying Remanufacturing to Protect Patient Safety Act of 2022
Sponsors
| Rep. Scott Peters [D-CA] | Rep. John Joyce [R-PA] | Rep. Kim Schrier [D-WA] | Rep. James McGovern [D-MA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-03-29 | House | Referred to the Subcommittee on Health. |
| 2022-03-28 | House | Referred to the House Committee on Energy and Commerce. |
| 2022-03-28 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/7253/all-info |
| Text | https://www.congress.gov/117/bills/hr7253/BILLS-117hr7253ih.pdf |
